Psychosocial impact of BRCA testing in young Black breast cancer survivors

Psychooncology. 2018 Dec;27(12):2778-2785. doi: 10.1002/pon.4887. Epub 2018 Oct 9.

Abstract

Objective: Prior studies demonstrating minimal psychological consequences for women receiving genetic counseling/genetic testing (GC/GT) for hereditary breast and ovarian cancer rely on predominantly Caucasian women. We conducted a prospective follow-up of a subset of participants from a population-based study of Black breast cancer (BC) survivors receiving GC/GT for BRCA1 and BRCA2 mutations.

Methods: Black women with invasive BC at age ≤ 50 years diagnosed between 2009 and 2012 were recruited through the Florida Cancer Registry. Participants (n = 215, age M = 44.7, SD = 6.2) were offered telephone pre- and post-test GC, a subset completed questionnaires assessing sociodemographic, clinical, and psychosocial variables.

Results: There were no baseline differences in cancer-related distress, psychological distress, or quality of life between test result groups. Social well-being improved in women receiving negative results (P = .01), but no other outcomes demonstrated significant changes over time between groups.

Conclusions: Our study is among the first to demonstrate minimal negative psychosocial outcomes following GC/GT among young Black BC survivors, irrespective of test results.

Keywords: Black; anxiety; breast cancer survivor; cancer; distress; genetic counseling; genetic testing; health disparities; oncology; psychosocial outcomes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • BRCA1 Protein
  • Black or African American / psychology*
  • Breast Neoplasms / psychology*
  • Cancer Survivors / psychology*
  • Cohort Studies
  • Female
  • Florida
  • Genetic Counseling / psychology*
  • Genetic Testing / methods
  • Humans
  • Middle Aged
  • Prospective Studies
  • Quality of Life / psychology
  • Surveys and Questionnaires

Substances

  • BRCA1 Protein
  • BRCA1 protein, human